Home›Stock Screener›Bharat Parenterals›Quarterly Results

Bharat Parenterals Quarterly Results

Latest Quarter Net Profit
₹-9 Cr
QSept 2025
Quarterly Results

Bharat Parenterals quarterly results. In Sept 2025, Bharat Parenterals (BPLPHARMA) reported revenue ₹68 Cr and net profit ₹-9 Cr — revenue -10.5% YoY. Review BPLPHARMA earnings valuation to evaluate earnings-based valuation against sector peers.

BPLPHARMA Quarterly Results — Revenue, Profit & EPS Highlights

Bharat Parenterals latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Bharat Parenterals share price chart.

  • Revenue of ₹68 Cr in Sept 2025 (-35.8% vs Mar 2025, -10.5% vs Sept 2024)
  • Net Profit of ₹-9 Cr in Sept 2025 (+0.0% vs Mar 2025, +50.0% vs Sept 2024)
  • EBITDA of ₹4 Cr in Sept 2025 (+0.0% vs Mar 2025)
  • Operating Margin of 1.0% in Sept 2025 (-1.0pp vs Mar 2025)
  • Earnings Per Share of ₹-14.00 in Sept 2025 (+2.8% vs Mar 2025)

Bharat Parenterals Quarterly Results — Revenue, EBITDA, Net Profit & EPS

BPLPHARMA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 QoQ YoY
Revenue (₹ Cr) 68 106 117 76 71 -35.8% -10.5%
Net Profit (₹ Cr) -9 -9 -1 -18 -3 - -
EBITDA (₹ Cr) 4 4 15 -4 4 - -
EPS (₹) -14.00 -14.40 -1.00 -27.00 -0.62 - -
Operating Margin (%) 1.0% 2.0% 12.0% -11.0% 1.0% - -

BPLPHARMA Share Price Trend — 1-Year Movement Across Quarterly Results

Bharat Parenterals 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check BPLPHARMA market capitalization to track the company's total market size over time.

Profitability Ratios

Profit Margin -13.2%
EBITDA Margin 5.9%
Operating Margin 1.0%
ROE (Annual) -10.6%

Balance Sheet Highlights

Total Assets ₹649 Cr
Total Equity ₹339 Cr
Current Assets ₹356 Cr
Current Liabilities ₹90 Cr

Cash Flow Analysis

Operating Cash Flow ₹-27 Cr
Investing Cash Flow ₹-137 Cr
Financing Cash Flow ₹156 Cr
Net Cash Flow ₹-8 Cr

Current Market Data

Current Price ₹1726.90
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Sept 2024 76
Jun 2025 117
Mar 2025 106
Sept 2025 68

Net Profit Trend (₹ Cr)

Sept 2024 -18
Jun 2025 -1
Mar 2025 -9
Sept 2025 -9

Operating Margin Trend (%)

Sept 2024 -11.0%
Jun 2025 12.0%
Mar 2025 2.0%
Sept 2025 1.0%

BPLPHARMA vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Bharat Parenterals latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹244,124.91 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Laurus Labs
Mar 2026 		₹109,629.35 Cr 1971.4 1,823 282 -10.5% - 15.5% 381.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores